Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

Inclusion Criteria: * overall healthy subjects; * non-childbearing potential females included Exclusion Criteria: * history of significant sensitivity to any drug; * positive test for HAV IgM, HBsAg, anti-HCV Ab or anti-HIV Ab; * history of gastrointestinal issues or procedures; * history of seizures, diabetes or cancer (except basal cell carcinoma); * clinically significant cardiovascular, respiratory (except mild asthma), renal, gastrointestinal, hematologic, neurologic, thyroid, or any uncontrolled medical illness or psychiatric disorder; * use of tobacco or nicotine-containing products with the 6-month period prior to study drug administration; * donation or loss of 550 mL or more blood volume or receipt of a transfusion of any blood product within 8 weeks prior to study drug administration; * abnormal screening laboratory results that are considered clinically significant by the investigator; * current enrollment in another clinical study; * previous enrollment in this study; * recent (6-month) history of drug/alcohol abuse that could preclude adherence to the protocol; * pregnant or breastfeeding female; * requirement for any OTC and/or prescription medication, vitamins and/or herbal supplements on a regular basis